Form 4 for ALZN Alzamend Neuro, Inc.
Accepted 2023-03-20 00:00:00 ET · period of report 2023-03-16 · accession 0001214659-23-004021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-03-20 | 2023-03-16+ | ALZN | AULT MILTON C III | 10% | P - Purchase | $0.4611 | +9,000 | 11.06M | +0.1% | +$4,150 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-17 | P | A | 5,000 | $0.43 | 11,060,001 | I By Ault Lending, LLC | — | — | (F2) Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AA"). Mr. Ault, the Executive Chairman of AA, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending. |
| 2 | Common | Common Stock | 2023-03-16 | P | A | 4,000 | $0.5 | 11,055,001 | I By Ault Lending, LLC | — | — | (F1) The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.5014. The range of purchase prices on the transaction date was $0.5014 to $0.5015 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. (F2) Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AA"). Mr. Ault, the Executive Chairman of AA, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending. |